Literature DB >> 8078396

Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology.

H F Löhr1, J F Schlaak, G Gerken, B Fleischer, H P Dienes, K H Meyer zum Büschenfelde.   

Abstract

Cytokines released by infiltrating T cells may contribute to the hepatic injury in chronic hepatitis. Therefore, we characterized peripheral blood- and liver-infiltrating T cells from patients with chronic hepatitis of different etiology and determined the T cell phenotypes and the cytokine release. Liver tissue and peripheral blood-derived T cells from patients with autoimmune hepatitis and primary biliary cirrhosis predominantly expressed CD4-molecules and the alpha- and beta-chains of the T cell receptor (TCR). In chronic viral hepatitis B and C, liver- and blood-derived T cells were preferentially CD8+ T cells expressing the alpha beta TCR. Mitogenic stimulation with irradiated Daudi lymphoma cells and phytohemagglutinin led to a strong release of interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha) and interleukin-2 (IL-2) by T cells in patients with chronic hepatitis and in healthy controls. T cells from patients with primary biliary cirrhosis and some patients with autoimmune hepatitis showed a significantly higher secretion of interleukin-4 (IL-4) and interleukin-10 (IL-10) than T cells from patients with chronic viral hepatitis or healthy controls. Histologic inflammatory activity did not correlate with the amount of cytokines released after mitogenic activation. In conclusion, liver tissue and peripheral blood T cells of patients with autoimmune hepatitis and primary biliary cirrhosis were dominated by CD4+ TCR alpha beta+ T helper/inducer cells, whereas in chronic viral hepatitis an enrichment of CD8+ TCR alpha beta + cytotoxic/suppressor T cells was observed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8078396     DOI: 10.1111/j.1600-0676.1994.tb00067.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  33 in total

1.  Cytokine profile in the liver of primary biliary cirrhosis.

Authors:  T Nagano; K Yamamoto; S Matsumoto; R Okamoto; M Tagashira; N Ibuki; S Matsumura; K Yabushita; N Okano; T Tsuji
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

Review 2.  MDSC in autoimmunity.

Authors:  James G Cripps; James D Gorham
Journal:  Int Immunopharmacol       Date:  2011-02-21       Impact factor: 4.932

3.  Concentrations of cytokines, soluble interleukin-2 receptor, and soluble CD30 in sera of patients with hepatitis B virus infection during acute and convalescent phases.

Authors:  Francisca Monsalve-De Castillo; Tania A Romero; Jesús Estévez; Luciana L Costa; Ricardo Atencio; Leticia Porto; Diana Callejas
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

4.  Scavenger receptor A restrains T-cell activation and protects against concanavalin A-induced hepatic injury.

Authors:  Daming Zuo; Xiaofei Yu; Chunqing Guo; Hongxia Wang; Jie Qian; Huanfa Yi; Xiao Lu; Zhi-Ping Lv; John R Subjeck; Huiping Zhou; Arun J Sanyal; Zhengliang Chen; Xiang-Yang Wang
Journal:  Hepatology       Date:  2013-01       Impact factor: 17.425

5.  Late relapse of type 1 autoimmune hepatitis after corticosteroid withdrawal.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-04-29       Impact factor: 3.199

6.  Critical contribution of liver natural killer T cells to a murine model of hepatitis.

Authors:  K Takeda; Y Hayakawa; L Van Kaer; H Matsuda; H Yagita; K Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

7.  End-organ damage in a mouse model of fulminant liver inflammation requires CD4+ T cell production of IFN-gamma but is independent of Fas.

Authors:  Richard T Robinson; Jing Wang; James G Cripps; Michael W Milks; Kathryn A English; Todd A Pearson; James D Gorham
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  A case of autoimmune hepatitis exacerbated by the administration of etanercept in the patient with rheumatoid arthritis.

Authors:  Koji Harada; Yasuhiro Akai; Sachi Koyama; Yasuhide Ikenaka; Yoshihiko Saito
Journal:  Clin Rheumatol       Date:  2008-06-18       Impact factor: 2.980

9.  Increased bcl-2 expression in lymphocytes and its association with hepatocellular damage in patients with autoimmune hepatitis.

Authors:  M Yachida; K Kurokohchi; K Arima; M Nishioka
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

10.  Immune responses in autoimmune hepatitis: effect of prednisone and azathioprine treatment: case report.

Authors:  Martin H Bluth; Stephan Kohlhoff; Kevin B Norowitz; Jonathan I Silverberg; Seto Chice; M Nowakowski; Helen G Durkin; Tamar A Smith-Norowitz
Journal:  Int J Med Sci       Date:  2009-06-30       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.